The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

May. 28, 2025
Applicant:

Institute of Animal Science of Chinese Academy of Agricultural Sciences, Beijing, CN;

Inventors:

Kui Li, Beijing, CN;

Yulian Mu, Beijing, CN;

Zhiguo Liu, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6816 (2018.01); C12N 9/22 (2006.01); C12N 15/11 (2006.01); C12Q 1/686 (2018.01); G01N 21/64 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6816 (2013.01); C12N 9/226 (2025.05); C12N 15/11 (2013.01); G01N 21/6428 (2013.01); C12N 2310/20 (2017.05); C12N 2320/10 (2013.01); C12Q 1/686 (2013.01); G01N 2021/6439 (2013.01);
Abstract

A method for detecting bi-allelic gene edited cells based on CRISPR/Cas12a technology is provided. The method provides crRNA, a nucleotide sequence of which that binds target is SEQ ID NO: 6. The crRNA is transcribed from a transcription template in vitro; the transcription template is a product obtained by annealing a single stranded DNA molecule shown in SEQ ID NO: 10 and a single stranded DNA molecule shown in SEQ ID NO: 13. The method provides crRNA of CD71 gene and constructs a CRISPR/Cas12a system using the same for CRISPR/Cas12a detection, achieving the screening for CRISPR/Cas9 induced CD71 gene bi-allelic gene edited cells. This method is simple, easy, fast, and cost-effective for screening a large number of mutant cells.


Find Patent Forward Citations

Loading…